Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
South San Francisco
Biotech
Genentech's CEO on the next 50 years of the original biotech
Genentech CEO Ashley Magarge told Fierce how its AI collaborations, campus overhaul and late-stage pipeline are future-proofing the organization.
Darren Incorvaia
Oct 1, 2026 8:00am
Genentech lets 118 staffers go in another HQ layoff round
Oct 29, 2025 4:55pm
Genentech is laying off 93 staffers in South San Francisco
Aug 28, 2024 10:40am
PACT unveils venture tied to diversion of some 50 staffers
Oct 3, 2022 3:33pm
Phase 3 migraine flop squashes Satsuma's stock price
Sep 11, 2020 8:20am
E-Scape Bio hires GSK neuroscience alum as new CSO
Mar 19, 2020 10:20am
